These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3121288)

  • 21. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.
    Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability studies of drugs with nonlinear pharmacokinetics: II. Absolute bioavailability of intravenous phenytoin prodrug at therapeutic phenytoin serum concentrations determined by double-stable isotope technique.
    Browne TR; Szabo GK; McEntegart C; Evans JE; Evans BA; Miceli JJ; Quon C; Dougherty CL; Kres J; Davoudi H
    J Clin Pharmacol; 1993 Jan; 33(1):89-94. PubMed ID: 8429121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patients.
    Kanji S; McKinnon PS; Barletta JF; Kruse JA; Devlin JW
    Crit Care Med; 2003 May; 31(5):1347-52. PubMed ID: 12771601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative bioavailability of 2 oral solid phenytoin dosage forms.
    Naik D; Morton DJ
    Cent Afr J Med; 1989 Apr; 35(4):384-8. PubMed ID: 2605620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin absorption in volunteers receiving selected enteral feedings.
    Guidry JR; Eastwood TF; Curry SC
    West J Med; 1989 Jun; 150(6):659-61. PubMed ID: 2501937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction of Phenytoin with Enteral Formulas, Proteins, and Dietary Fiber in Vitro and in Vivo].
    Kuwabara N; Ohta-Shimizu M; Fuwa F; Tsugita M; Sato N; Sato S; Nakagawa S
    Yakugaku Zasshi; 2023; 143(1):85-94. PubMed ID: 36596543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative bioavailability of atovaquone suspension when administered with an enteral nutrition supplement.
    Freeman CD; Klutman NE; Lamp KC; Dall LH; Strayer AH
    Ann Pharmacother; 1998 Oct; 32(10):1004-7. PubMed ID: 9793589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules.
    Fitzsimmons WE; Garnett WR; Comstock TJ; Pellock JM
    Epilepsia; 1986; 27(4):464-8. PubMed ID: 3720707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenytoin and enteral feedings: does evidence support an interaction?
    Au Yeung SC; Ensom MH
    Ann Pharmacother; 2000; 34(7-8):896-905. PubMed ID: 10928402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension.
    Bass J; Miles MV; Tennison MB; Holcombe BJ; Thorn MD
    Epilepsia; 1989; 30(3):364-9. PubMed ID: 2498074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex.
    Walker MC; Alavijeh MS; Shorvon SD; Patsalos PN
    Epilepsia; 1996 May; 37(5):421-7. PubMed ID: 8617169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and Chronic Administrations of Rheum palmatum Reduced the Bioavailability of Phenytoin in Rats: A New Herb-Drug Interaction.
    Chi YC; Juang SH; Chui WK; Hou YC; Chao PD
    Evid Based Complement Alternat Med; 2012; 2012():701205. PubMed ID: 22829856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenytoin malabsorption after jejunostomy tube delivery.
    Rodman DP; Stevenson TL; Ray TR
    Pharmacotherapy; 1995; 15(6):801-5. PubMed ID: 8602393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenytoin interaction with enteral feedings administered through nasogastric tubes.
    Fleisher D; Sheth N; Kou JH
    JPEN J Parenter Enteral Nutr; 1990; 14(5):513-6. PubMed ID: 2122025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenytoin pharmacokinetics: before and after folic acid administration.
    Berg MJ; Fincham RW; Ebert BE; Schottelius DD
    Epilepsia; 1992; 33(4):712-20. PubMed ID: 1628589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.